After seven years of PREPARE it is time to look back. Many ground-breaking research studies, data analyses, reviews and surveys have been performed under the umbrella of the PREPARE and also RECOVER in their research response to the COVID-19 pandemic. It is important to take a look at what we have achieved, and especially what can we learn from it. And finally, we als... read more

The COVID-19 pandemic changed the way of performing clinical therapeutic research. The platform trial REMAP-CAP proved to be highly efficient and provided evidence-based guidance for treatment of patients hospitalized with COVID-19. Platforms clearly represent the future of clinical trials. In this session the beauty, complexity and results from the REMAP-CAP trial wi... read more

The world has been astonished by the impact of the COVID-19 pandemic, which we all hope to see defeated by the application of top-level science of the type promoted by the PREPARE consortium. In this session, we will provide a top-level overview of just what can be achieved in preparing for the next pandemic and just how important it is that we maintain our science ba... read more

This webinar focuses on arboviruses in Europe, presenting data from experiences of annual outbreaks of West Nile virus in Romania, and an overview of the results from the PREPARE MERMAIDS Arbovirus, a seasonal observational study set in hospital sites in seven countries across southeast Europe from May 2016 to January 2020.  

MERMAIDS is the Multi-centre EuRopean study of MAjor Infectious Disease Syndromes. In this webinar we will take you on a journey of exploring the reasons as to why some people with acute respiratory infections become more unwell than others. Can the expression of specific genes tell us why some people go on to develop more severe disease and is this related to other c... read more

The Adaptive Platform Trial for Community-Acquired Pneumonia, REMAP-CAP, launched its second video. The video shows the smart, efficient and optimized design of REMAP-CAP.  As an adaptive platform, REMAP-CAP is designed to adapt in the event of a pandemic, increasing the likelihood of patients receiving an effective treatment. Since the COVID-19 outbreak, the pla... read more

REMAP-CAP, an Adaptive Platform Trial for Community-Acquired Pneumonia, launched its first in a series of videos. The video shows the uniqueness, smart, and easy-to-handle design of this trial. As an adaptive platform, REMAP-CAP is designed to adapt in the event of a pandemic, increasing the likelihood of patients receiving an effective treatment. Combatting antimi... read more

"Levels of education and exposure all influence the way people respond to research". Watch our interview with Dr. John Amuasi!

Dr. Nina Gobat underlines the importance of public engagement in the PREPARE project.

"The focus of PREPARE is to look to how we can do clinical research during an infectious disease outbreak". Watch the interview of Dr. Nina Gobat on PREPARE!